During the last session, Nevro Corp (NYSE:NVRO)’s traded shares were 0.35 million, with the beta value of the company hitting 0.93. At the end of the trading day, the stock’s price was $5.53, reflecting an intraday gain of 0.36% or $0.02. The 52-week high for the NVRO share is $22.64, that puts it down -309.4 from that peak though still a striking 20.8% gain since the share price plummeted to a 52-week low of $4.38. The company’s market capitalization is $206.18M, and the average intraday trading volume over the past 10 days was 0.37 million shares, and the average trade volume was 612.49K shares over the past three months.
Nevro Corp (NVRO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.44. NVRO has a Sell rating from 2 analyst(s) out of 15 analysts who have looked at this stock. 6 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.81.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Nevro Corp (NYSE:NVRO) trade information
Nevro Corp (NVRO) registered a 0.36% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.36% in intraday trading to $5.53, hitting a weekly high. The stock’s 5-day price performance is 20.74%, and it has moved by 11.72% in 30 days. Based on these gigs, the overall price performance for the year is -62.12%. The short interest in Nevro Corp (NYSE:NVRO) is 3.13 million shares and it means that shorts have 7.25 day(s) to cover.
The consensus price target of analysts on Wall Street is $7, which implies an increase of 21.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $125 respectively. As a result, NVRO is trading at a discount of -2160.4% off the target high and 9.58% off the low.
Nevro Corp (NVRO) estimates and forecasts
Statistics show that Nevro Corp has underperformed its competitors in share price, compared to the industry in which it operates. Nevro Corp (NVRO) shares have gone down -51.02% during the last six months, with a year-to-date growth rate less than the industry average at -9.35% against 14.60. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -24.60% this quarter and then drop -168.00% in the quarter after that. In the rating firms’ projections, revenue will decrease -5.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 93.07M as predicted by 15 analyst(s). Meanwhile, a consensus of 15 analyst(s) estimates revenue growth to 103.33M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 103.86M and 116.18M respectively. In this case, analysts expect current quarter sales to shrink by -10.40% and then drop by -11.10% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -9.37%. While earnings are projected to return -6.17% in 2024.
NVRO Dividends
Nevro Corp is due to release its next quarterly earnings on 2024-Nov-11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Nevro Corp (NYSE:NVRO)’s Major holders
Nevro Corp insiders own 3.73% of total outstanding shares while institutional holders control 96.76%, with the float percentage being 100.51%. ARROWMARK COLORADO HOLDINGS LLC is the largest shareholder of the company, while 218.0 institutions own stock in it. As of 2024-06-30, the company held over 4.29 million shares (or 11.7615% of all shares), a total value of $36.11 million in shares.
The next largest institutional holding, with 3.67 million shares, is of ARMISTICE CAPITAL, LLC’s that is approximately 10.0693% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $30.92 million.
